These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33276814)

  • 1. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.
    Curtis JR; Xie F; Crowson CS; Sasso EH; Hitraya E; Chin CL; Bamford RD; Ben-Shachar R; Gutin A; Flake DD; Mabey B; Lanchbury JS
    Arthritis Res Ther; 2020 Dec; 22(1):282. PubMed ID: 33276814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis.
    Sasso EH; Mabey B; Flake DD; Hitraya E; Chin CL; Ben-Shachar R; Gutin A; Lanchbury JS; Curtis JR
    PLoS One; 2024; 19(5):e0296459. PubMed ID: 38709770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
    Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
    Curtis JR; Xie F; Chen L; Saag KG; Yun H; Muntner P
    Ann Rheum Dis; 2018 Mar; 77(3):386-392. PubMed ID: 29269418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies.
    Curtis JR; Weinblatt ME; Shadick NA; Brahe CH; Østergaard M; Hetland ML; Saevarsdottir S; Horton M; Mabey B; Flake DD; Ben-Shachar R; Sasso EH; Huizinga TW
    Arthritis Res Ther; 2021 Jan; 23(1):1. PubMed ID: 33397438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis.
    Curtis JR; Flake DD; Weinblatt ME; Shadick NA; Østergaard M; Hetland ML; Brahe CH; Hwang YG; Furst DE; Strand V; Etzel CJ; Pappas DA; Wang X; Hwang CC; Sasso EH; Gutin A; Hitraya E; Lanchbury JS
    Rheumatology (Oxford); 2019 May; 58(5):874-883. PubMed ID: 30590790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
    Ma MHY; Defranoux N; Li W; Sasso EH; Ibrahim F; Scott DL; Cope AP
    Arthritis Res Ther; 2020 Jun; 22(1):158. PubMed ID: 32580789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
    Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
    Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
    Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW
    Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
    Curtis JR; Brahe CH; Østergaard M; Lund Hetland M; Hambardzumyan K; Saevarsdottir S; Wang X; Flake Ii DD; Sasso EH; Huizinga TW
    Curr Med Res Opin; 2019 Sep; 35(9):1483-1493. PubMed ID: 30777458
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
    Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
    Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis.
    Curtis JR; Greenberg JD; Harrold LR; Kremer JM; Palmer JL
    Semin Arthritis Rheum; 2018 Feb; 47(4):472-477. PubMed ID: 28947312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multi-biomarker disease activity test for rheumatoid arthritis.
    Centola M; Cavet G; Shen Y; Ramanujan S; Knowlton N; Swan KA; Turner M; Sutton C; Smith DR; Haney DJ; Chernoff D; Hesterberg LK; Carulli JP; Taylor PC; Shadick NA; Weinblatt ME; Curtis JR
    PLoS One; 2013; 8(4):e60635. PubMed ID: 23585841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.
    Bakker MF; Cavet G; Jacobs JW; Bijlsma JW; Haney DJ; Shen Y; Hesterberg LK; Smith DR; Centola M; van Roon JA; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Oct; 71(10):1692-7. PubMed ID: 22596166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States.
    Curtis JR; Xie F; Yang S; Danila MI; Owensby JK; Chen L
    J Rheumatol; 2019 Mar; 46(3):237-244. PubMed ID: 30442830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study.
    Hirata S; Li W; Defranoux N; Cavet G; Bolce R; Yamaoka K; Saito K; Tanaka Y
    Mod Rheumatol; 2015 May; 25(3):344-9. PubMed ID: 25295918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
    Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH
    Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores.
    Chernoff D; Scott Eastman P; Hwang CC; Flake DD; Wang X; Kivitz A; Curtis JR
    Clin Rheumatol; 2019 Feb; 38(2):437-445. PubMed ID: 30159791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.